Gore Range CapitalJul 8, 2019Cristina Griffin Joins Or-Genix Therapeutics as Chief Business OfficerCristina Griffin Joins Or-Genix Therapeutics as Chief Business Officer
Gore Range CapitalJun 26, 2019Genomic diagnostics provider Castle Biosciences files for a $58 million IPO Castle Biosciences filed on Wednesday with the SEC to raise up to $58 million in an initial public offering.
Gore Range CapitalMay 3, 2019Does This Age Make Me Look Old? The definition of old is becoming increasingly fluid. There is no typical ‘old’ any longer.
Gore Range CapitalFeb 25, 2019Future of Skin Health - Takeaways from IMCASOver the past decade, skin health has evolved to become a complex, deep and diverse category that touches a huge portion of the population.
Gore Range CapitalFeb 4, 2019LEO Pharma Joins Gore Range Capital as Strategic InvestorPartnership melds firms' commitment to innovation in dermatology and patient-centric approach.
Gore Range CapitalJan 14, 2019Gore Range Capital Closes Debut FundGore Range Capital today announced that its first fund is closed to new investors